And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | November 14, 2019

Melanoma Rates Drop Sharply Among Teens, Young Adults

Cases of melanoma among U.S. adolescents and young adults declined markedly from 2006 to 2015 - even as the skin cancer's incidence continued to increase among older adults and the general population during the span, new research in...

Read More

News | November 14, 2019

Allergan Pays Exicure $25M upfront in Collaboration Deal to Develop Hair Loss Treatment

Allergan Pharmaceuticals International Limited has entered into a global collaboration agreement with Exicure to discover and develop novel treatments for hair loss disorders based on Exicure’s proprietary SNA technology. Allergan...

Read More

News | November 13, 2019

Cassiopea Enrolls First Patient in Phase II Trial of Clascoterone Solution for the Treatment of Androgenetic Alopecia in Females

After receiving approval from the German Authority BfArM and the coordinating ethical committee, Cassiopea SpA is now enrolling the first patient in a Phase II trial investigating clascoterone solution for the treatment of androgenetic...

Read More

News | November 10, 2019

Post-Market Price Changes Alone Account for Most Recent Spending Growth for Biologics, and Rebates Have Little Impact

Annual spending on biologics by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016, according to research presented at the 2019 ACR/ARP Annual Meeting in Atlanta.  Post-market drug price changes alone accounted for...

Read More

News | November 10, 2019

Live Zoster Vaccine Safe and Effective for Patients on TNF Blockers

The live zoster virus vaccine is safe for people who are currently receiving tumor necrosis factor inhibitor (TNFi) biologic therapies for various indications, according to new research findings presented this week at the 2019 ACR/ARP...

Read More

Advertisement

The Latest News

Advertisement

View more